We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Donnelley Financial Solutions
DFIN
$1.26B
| $1.53K | ﹤0.01% |
35
+30
| +600% | +$1.66K |
2022 Q1
12 quarters
|
|
|
MAG
3027
DELISTED
MAG Silver
MAG
| $1.53K | ﹤0.01% |
+100
| New | +$1.55K |
2025 Q1
0 quarters
|
|
3028
Alpha Metallurgical Resources
AMR
$2.14B
| $1.5K | ﹤0.01% |
12
-9
| -43% | -$1.47K |
2019 Q1
24 quarters
|
|
3029
iShares New York Muni Bond ETF
NYF
$1.6B
| $1.5K | ﹤0.01% |
28
| – | – |
2023 Q3
6 quarters
|
|
3030
Civeo
CVEO
$309M
| $1.5K | ﹤0.01% |
+65
| New | +$1.52K |
2025 Q1
0 quarters
|
|
3031
Middlesex Water
MSEX
$1.03B
| $1.49K | ﹤0.01% |
23
-58
| -72% | -$3.15K |
2021 Q1
16 quarters
|
|
3032
BNY Mellon International Equity ETF
BKIE
$1.32B
| $1.47K | ﹤0.01% |
+57
| New | +$1.46K |
2025 Q1
0 quarters
|
|
3033
Acco Brands
ACCO
$416M
| $1.46K | ﹤0.01% |
349
+326
| +1,417% | +$1.6K |
2021 Q1
16 quarters
|
|
3034
Tompkins Financial
TMP
$1.41B
| $1.45K | ﹤0.01% |
23
+14
| +156% | +$938 |
2024 Q3
2 quarters
|
|
3035
Orrstown Financial Services
ORRF
$817M
| $1.44K | ﹤0.01% |
48
+15
| +45% | +$502 |
2024 Q4
1 quarter
|
|
3036
AdvanSix
ASIX
$440M
| $1.43K | ﹤0.01% |
63
-889
| -93% | -$24.7K |
2016 Q4
33 quarters
|
|
3037
Centerspace
CSR
$936M
| $1.43K | ﹤0.01% |
22
+18
| +450% | +$1.14K |
2023 Q2
7 quarters
|
|
3038
Millicom
TIGO
$13.7B
| $1.42K | ﹤0.01% |
47
+21
| +81% | +$579 |
2024 Q3
2 quarters
|
|
3039
Simmons First National
SFNC
$3.16B
| $1.42K | ﹤0.01% |
69
| – | – |
2017 Q3
30 quarters
|
|
3040
RxSight
RXST
$193M
| $1.41K | ﹤0.01% |
56
+53
| +1,767% | +$1.57K |
2024 Q2
3 quarters
|
|
3041
Invesco Pharmaceuticals ETF
PJP
$555M
| $1.41K | ﹤0.01% |
16
| – | – |
2023 Q3
6 quarters
|
|
3042
ProShares UltraPro Russell2000
URTY
$255M
| $1.37K | ﹤0.01% |
40
| – | – |
2024 Q1
4 quarters
|
|
3043
Enova International
ENVA
$4.45B
| $1.35K | ﹤0.01% |
14
-16
| -53% | -$1.65K |
2022 Q2
11 quarters
|
|
3044
State Street SPDR Portfolio TIPS ETF
SPIP
$1.04B
| $1.34K | ﹤0.01% |
51
| – | – |
2024 Q3
2 quarters
|
|
3045
PGIM Global High Yield Fund
GHY
$442M
| $1.34K | ﹤0.01% |
+100
| New | +$1.31K |
2025 Q1
0 quarters
|
|
3046
Tejon Ranch
TRC
$443M
| $1.33K | ﹤0.01% |
84
+17
| +25% | +$270 |
2024 Q1
4 quarters
|
|
3047
United States Oil Fund
USO
$2.07B
| $1.31K | ﹤0.01% |
17
| – | – |
2024 Q3
2 quarters
|
|
3048
Protagonist Therapeutics
PTGX
$8.27B
| $1.31K | ﹤0.01% |
27
| – | – |
2024 Q2
3 quarters
|
|
3049
Universal Insurance Holdings
UVE
$1.31B
| $1.3K | ﹤0.01% |
55
| – | – |
2024 Q1
4 quarters
|
|
3050
indie Semiconductor
INDI
$429M
| $1.3K | ﹤0.01% |
+637
| New | +$2.22K |
2025 Q1
0 quarters
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.